Enterobacter spp
% resistance to ceftazidime per hospital
All clinical specimens
(July - December 2022)

Hospital Medical Wards Surgical Wards ICU
%entb/total isolates Isolates tested %NS %R %I %entb/total isolates Isolates tested %NS %R %I %entb/total isolates Isolates tested %NS %R %I
GR001 1.7% 16 43.8 43.8 0.0 2.2% 12 25.0 25.0 0.0 1.2% 4
GR005 0.3% 1 1.6% 4 0.8% 2
GR007 1.7% 7 28.6 28.6 0.0 2.6% 6 1.1% 2
*GR011 10.8% 61 60.7 60.7 0.0 4.7% 10 30.0 30.0 0.0 7.4% 14 42.9 42.9 0.0
GR012 1.3% 1 5.3% 1
GR014 2.0% 30 13.3 13.3 0.0 2.5% 8 25.0 25.0 0.0 0.5% 2
GR018 3.8% 9 66.7 66.7 0.0 1.9% 3 1.5% 3
GR024 1.2% 11 27.3 27.3 0.0 2.2% 6
GR026 0.4% 1 1.9% 2
GR030 1.4% 6 1.3% 1 1.4% 3
GR031 0.9% 9 22.2 22.2 0.0 1.6% 9 22.2 22.2 0.0 0.7% 2
GR032 2.2% 9 11.1 11.1 0.0 5.3% 6 0.7% 1
GR033 2.0% 22 18.2 18.2 0.0 3.5% 23 17.4 17.4 0.0 0.4% 2
GR035 2.1% 13 38.5 38.5 0.0 3.6% 9 22.2 22.2 0.0 2.6% 7 57.1 57.1 0.0
GR037 1.9% 25 40.0 40.0 0.0 2.6% 9 44.4 44.4 0.0 1.6% 5
GR039 1.6% 18 33.3 33.3 0.0 4.1% 20 40.0 40.0 0.0 0.6% 4
GR040 1.3% 17 47.1 47.1 0.0 2.7% 17 5.9 5.9 0.0 2.2% 8 12.5 12.5 0.0
GR041 2.8% 12 25.0 25.0 0.0 3.5% 8 25.0 25.0 0.0 1.6% 4
GR042 0.5% 2
GR046 1.3% 2 3.4% 2 2.8% 2
GR047 2.0% 29 37.9 37.9 0.0 4.4% 38 57.9 57.9 0.0 3.8% 5
GR048 4.3% 3 3.0% 2
GR049 3.3% 10 60.0 60.0 0.0 3.1% 5 4.1% 6
GR050 0.9% 4 3.6% 11 27.3 27.3 0.0 0.7% 1
GR052 1.3% 2 5.2% 4
GR056 2.1% 10 30.0 30.0 0.0 1.8% 5 5.1% 7 0.0 0.0 0.0
GR062 1.3% 10 20.0 20.0 0.0 1.9% 5 0.7% 1
GR070 2.4% 50 24.0 24.0 0.0 3.3% 31 32.3 32.3 0.0 1.1% 4
GR076 1.9% 41 41.5 41.5 0.0 3.5% 20 30.0 30.0 0.0 1.8% 12 41.7 41.7 0.0
GR079 0.6% 1 10.5% 2
GR080 1.7% 6 2.7% 8 12.5 12.5 0.0 0.8% 2
GR082 2.2% 28 35.7 35.7 0.0 3.0% 26 30.8 30.8 0.0 2.1% 11 36.4 36.4 0.0
GR083 1.2% 4 1.7% 4 2.2% 7 71.4 71.4 0.0
Weighted Average 2.1% 473 35.1 35.1 0.0 3.2% 319 29.2 29.2 0.0 1.6% 121 35.5 35.5 0.0
Hospital Mean 34.5 34.5 0.0 28.0 28.0 0.0 37.4 37.4 0.0
* Children's Hospital

Back